Moneycontrol PRO
Upcoming Event:Super25 3.0- India’s Largest Online Stock Traders Conference brought to you by Moneycontrol Pro & Espresso
you are here: HomeNewsWorld

Covax says needs $2 billion additional funding by June for supply of vaccines to poor countries

"If the world's leaders rally together, the original Covax objectives -– delivery of two billion doses of vaccines worldwide in 2021, and 1.8 billion doses to 92 lower-income economies by early 2022 -- are still well within reach," the mechanism's organisers -- which include the World Health Organization and the Gavi alliance -- said in a statement.

May 28, 2021 / 06:20 PM IST
Representative Image (Source: Shutterstock)

Representative Image (Source: Shutterstock)

The Covax global vaccine-sharing programme said Thursday it needs $2.0 billion in additional funding by the beginning of June in order to boost coronavirus inoculation programmes in lower-income countries.

"We need an additional $2 billion to lift coverage... up to nearly 30 percent, and we need it by June 2 to lock in supplies now so that doses can be delivered through 2021, and into early 2022," the mechanism's organisers -- which include the World Health Organization and the Gavi alliance -- said in a statement.

"If the world's leaders rally together, the original Covax objectives -– delivery of two billion doses of vaccines worldwide in 2021, and 1.8 billion doses to 92 lower-income economies by early 2022 -- are still well within reach," the statement said.

"But it will require governments and the private sector to urgently unlock new sources of doses, with deliveries starting in June, and funding so we can deliver."

Also Read | Global supply of COVAX hit due to coronavirus crisis in India, USAID tells lawmakers

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Covax said it has already delivered 70 million vaccine doses to 126 countries, but faces a shortfall of 190 million at the end of June because of the "severe impact on Covax's supply in the second quarter of this year... (from) the terrible surge of the virus in India".

India's Serum Institute is the world's largest vaccine manufacturer by volume, producing 1.5 billion doses a year even before the coronavirus pandemic hit.

Even though Covax will have larger volumes available later in the year through the deals it has secured with several manufacturers, "if we do not address the current, urgent shortfall the consequences could be catastrophic," the organisers warned.

Covax welcomed the vaccine pledges made so far by countries such as France, Germany, Sweden, Italy, Spain, New Zealand and the United Arab Emirates.

The United States has promised to supply around 80 million doses -- the largest donation from a single country -- but has so far not said how the jabs would be distributed or which countries would receive them.



Download your money calendar for 2022-23 here and keep your dates with your moneybox, investments, taxes

AFP
first published: May 28, 2021 06:20 pm
Sections
ISO 27001 - BSI Assurance Mark